Stage III Hepatocellular Carcinoma AJCC v7
6 clinical trials · Condition
◉ Watch Stage III Hepatocellular Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction (NCT03217253) | National Cancer Institute (NCI) | 2018-03-16 |
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
| Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer (NCT03186898) | NRG Oncology | 2018-01-26 |
| Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496) | M.D. Anderson Cancer Center | 2016-12-09 |
| Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01900002) | M.D. Anderson Cancer Center | 2013-09-13 |
| Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer (NCT01015833) | National Cancer Institute (NCI) | 2010-02-15 |
Track Stage III Hepatocellular Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.